News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
326,012 Results
Type
Article (19768)
Company Profile (84)
Press Release (306158)
Multimedia
Podcasts (25)
Webinars (8)
Section
Business (89272)
Career Advice (235)
Deals (13923)
Drug Delivery (38)
Drug Development (39606)
Employer Resources (28)
FDA (5633)
Job Trends (4722)
News (147434)
Policy (11180)
Tag
2027 Biotech Bay Standard (2)
2027 Pharm Country Standard (2)
Academia (752)
Accelerated approval (14)
Adcomms (2)
Allergies (82)
Alliances (24256)
ALS (84)
Alzheimer's disease (594)
Antibody-drug conjugate (ADC) (198)
Approvals (5894)
Artificial intelligence (267)
Autoimmune disease (113)
Automation (20)
Bankruptcy (88)
Best Places to Work (3930)
BIOSECURE Act (2)
Biosimilars (82)
Biotechnology (60)
Bladder cancer (114)
Brain cancer (29)
Breast cancer (420)
Cancer (3063)
Cardiovascular disease (208)
Career advice (201)
Career pathing (3)
CAR-T (205)
CDC (7)
Celiac Disease (1)
Cell therapy (452)
Cervical cancer (18)
Clinical research (34777)
Collaboration (993)
Company closure (2)
Compensation (519)
Complete response letters (16)
COVID-19 (2030)
CRISPR (54)
C-suite (498)
Cystic fibrosis (79)
Data (3975)
Denatured (7)
Depression (61)
Diabetes (215)
Diagnostics (2520)
Digital health (17)
Diversity (4)
Diversity, equity & inclusion (6)
Drug discovery (125)
Drug pricing (47)
Drug shortages (6)
Duchenne muscular dystrophy (106)
Earnings (28179)
Editorial (13)
Employer branding (3)
Employer resources (26)
Events (57899)
Executive appointments (628)
FDA (7335)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (911)
Gene editing (108)
Generative AI (14)
Gene therapy (290)
GLP-1 (349)
Government (1498)
Grass and pollen (6)
Guidances (239)
Healthcare (5346)
HIV (42)
Huntington's disease (27)
IgA nephropathy (68)
Immunology and inflammation (132)
Immuno-oncology (39)
Indications (55)
Infectious disease (2187)
Inflammatory bowel disease (100)
Inflation Reduction Act (10)
Influenza (79)
Intellectual property (117)
Interviews (37)
IPO (5591)
IRA (14)
Job creations (1114)
Job search strategy (182)
JPM (19)
Kidney cancer (11)
Labor market (20)
Layoffs (139)
Leadership (4)
Legal (2536)
Liver cancer (53)
Longevity (4)
Lung cancer (404)
Lymphoma (336)
Machine learning (19)
Management (8)
Manufacturing (322)
MASH (99)
Medical device (3158)
Medtech (3172)
Mergers & acquisitions (8956)
Metabolic disorders (544)
Multiple sclerosis (113)
NASH (10)
Neurodegenerative disease (160)
Neuropsychiatric disorders (40)
Neuroscience (1223)
NextGen: Class of 2026 (1775)
Non-profit (753)
Now hiring (13)
Obesity (214)
Opinion (132)
Ovarian cancer (123)
Pain (112)
Pancreatic cancer (140)
Parkinson's disease (142)
Partnered (13)
Patents (226)
Patient recruitment (269)
Peanut (31)
People (36946)
Pharmaceutical (14)
Pharmacy benefit managers (9)
Phase 1 (11838)
Phase 2 (16002)
Phase 3 (10596)
Pipeline (3135)
Policy (53)
Postmarket research (1027)
Preclinical (4352)
Press Release (17)
Prostate cancer (148)
Psychedelics (12)
Radiopharmaceuticals (89)
Rare diseases (436)
Real estate (2033)
Recruiting (15)
Regulatory (9282)
Reports (15)
Research institute (751)
Resumes & cover letters (29)
Rett syndrome (20)
RNA editing (13)
RSV (44)
Schizophrenia (69)
Series A (144)
Series B (198)
Service/supplier (4)
Sickle cell disease (52)
Special edition (7)
Spinal muscular atrophy (62)
Sponsored (11)
Startups (2157)
Stomach cancer (5)
Supply chain (46)
Tariffs (20)
The Weekly (18)
Vaccines (537)
Venture capital (44)
Weight loss (117)
Women's health (38)
Worklife (1)
Date
Last 7 days (306)
Last 30 days (1045)
Last 365 days (16956)
2026 (1548)
2025 (17211)
2024 (15744)
2023 (15653)
2022 (21495)
2021 (24634)
2020 (21364)
2019 (11898)
2018 (9069)
2017 (15274)
2016 (17676)
2015 (22055)
2014 (16639)
2013 (14066)
2012 (14659)
2011 (14272)
2010 (12567)
Location
Africa (316)
Alabama (35)
Arizona (99)
Arkansas (7)
Asia (19776)
Australia (2949)
California (6900)
Canada (1643)
China (587)
Colorado (259)
Connecticut (298)
Delaware (229)
Europe (47196)
Florida (713)
Georgia (184)
Hawaii (3)
Idaho (19)
Illinois (500)
India (28)
Indiana (198)
Iowa (10)
Japan (271)
Kansas (62)
Kentucky (16)
Louisiana (7)
Maine (11)
Maryland (613)
Massachusetts (4701)
Michigan (112)
Minnesota (247)
Mississippi (2)
Missouri (62)
Montana (10)
Nebraska (5)
Nevada (84)
New Hampshire (23)
New Jersey (1640)
New Mexico (6)
New York (1491)
North Carolina (639)
North Dakota (4)
Northern California (3398)
Ohio (158)
Oklahoma (7)
Oregon (20)
Pennsylvania (985)
Puerto Rico (6)
Rhode Island (19)
South America (558)
South Carolina (8)
Southern California (2654)
Tennessee (58)
Texas (1023)
United States (21575)
Utah (93)
Virginia (138)
Washington D.C. (30)
Washington State (532)
West Virginia (2)
Wisconsin (96)
Wyoming (1)
326,012 Results for "crossbeta biosciences b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.
December 15, 2025
·
3 min read
Press Releases
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
October 20, 2025
·
2 min read
Press Releases
Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025
November 20, 2025
·
6 min read
Press Releases
Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia
January 12, 2026
·
7 min read
Press Releases
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
January 12, 2026
·
11 min read
Press Releases
Character Biosciences Expands Leadership Team with Key Appointments and Announces Series B Extension
September 18, 2025
·
2 min read
Press Releases
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
November 14, 2025
·
4 min read
Press Releases
Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial
October 8, 2025
·
9 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences
January 7, 2026
·
3 min read
Press Releases
Concerto Biosciences Announces Positive Topline Results from Phase 1b Clinical Trial of ENS-002 in Patients with Atopic Dermatitis
October 29, 2025
·
6 min read
1 of 32,602
Next
